Comparative Effectiveness Core

比较有效性核心

基本信息

项目摘要

The program theme is to identify effective breast cancer screening strategies for women with diverse levels of breast cancer risk to maximize screening benefits while minimizing potential harms. Program aims follow the premise that breast cancer screening will be most effective when: guidelines are based on accurate risk estimates that are tied to the effectiveness and harms of screening tests; women and physicians are informed about screening test performance based on risk level; risk-based screening practices are equitable; and high-quality comparative effectiveness research results are disseminated into community practice. Program goals will be met through three complementary research projects and three shared resource cores. Project 1, Risk Assessment in Community Practice: Developing Better Models, will improve prediction of breast cancer and breast cancer subtypes among women of varying ages and race/ethnicity and evaluate whether predicted risk can be used to optimize screening outcomes. Project 2, Comparative Effectiveness of Imaging Strategies for Breast Cancer Screening in Community Practice, will characterize the performance of advanced imaging technologies and screening strategies according to age, race/ethnicity, breast density, and overall breast cancer risk. Project 3, Community-based Utilization of Breast Imaging Technologies, will assess risk-based screening in diverse populations and identify disparities in access and use of new technologies. The Administrative Core will support logistical requirements and facilitate communication and data sharing. The Biostatistics and Data Management Core will coordinate data collection, management, and analysis and will develop statistical methods. The Comparative Effectiveness Core will use simulation modeling to estimate long-term implications of different screening practices on population health. The program represents an integrated effort to improve screening with the overall aim of averting deaths from breast cancer while minimizing harms.
该计划的主题是为具有不同乳腺癌风险水平的女性确定有效的乳腺癌筛查策略,以最大限度地提高筛查益处,同时最大限度地减少潜在危害。方案目标遵循的前提是,乳腺癌筛查在以下情况下最有效:指导方针基于与筛查试验的有效性和危害相关的准确风险估计;妇女和医生了解基于风险水平的筛查试验性能;基于风险的筛查做法是公平的;高质量的比较有效性研究结果传播到社区实践中。计划目标将通过三个互补的研究项目和三个共享资源核心来实现。项目1,社区实践中的风险评估:开发更好的模型,将改善对不同年龄和种族/民族妇女乳腺癌和乳腺癌亚型的预测,并评估预测的风险是否可用于优化筛查结果。项目2,在社区实践中乳腺癌筛查成像策略的比较有效性,将根据年龄,种族/民族,乳腺密度和整体乳腺癌风险来描述先进成像技术和筛查策略的性能。项目3,以社区为基础的乳腺成像技术的利用,将评估不同人群中基于风险的筛查,并确定在获得和使用新技术方面的差距。行政核心将支持后勤需求,促进通信和数据共享。生物统计和数据管理核心将协调数据收集、管理和分析,并将开发统计方法。比较有效性核心将使用模拟建模来估计不同筛查实践对人群健康的长期影响。该计划代表了改善筛查的综合努力,其总体目标是避免乳腺癌死亡,同时尽量减少危害。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna N. A. Tosteson其他文献

Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results
  • DOI:
    10.1007/s11606-024-09128-4
  • 发表时间:
    2024-10-18
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Steven J. Atlas;Katherine L. Gallagher;Sydney E. McGovern;Amy J. Wint;Rebecca E. Smith;David G. Aman;Wenyan Zhao;Timothy E. Burdick;E. John Orav;Li Zhou;Adam Wright;Anna N. A. Tosteson;Jennifer S. Haas
  • 通讯作者:
    Jennifer S. Haas
ASO Visual Abstract: Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon-Cancer-Directed Surgery in the United States
  • DOI:
    10.1245/s10434-025-17469-5
  • 发表时间:
    2025-05-31
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Andrew P. Loehrer;Qianfei Wang;A. James O’Malley;Sandra L. Wong;Anna N. A. Tosteson
  • 通讯作者:
    Anna N. A. Tosteson
Optimal management strategies for HIV-infected patients who present with cough or dyspnea
  • DOI:
    10.1007/bf02598081
  • 发表时间:
    1992-05-01
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Kenneth A. Freedberg;Anna N. A. Tosteson;Deborah J. Cotton;Lee Goldman
  • 通讯作者:
    Lee Goldman
Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions
基于模型的绝经后骨质疏松症干预措施经济评估面临的挑战
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Anna N. A. Tosteson;Bengt Jönsson;Daniel T. Grima;B. O'brien;Dennis M. Black;Jonathan D. Adachi
  • 通讯作者:
    Jonathan D. Adachi
Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
病理学家与专家的一致意见以及乳腺导管原位癌分类方案的可重复性。
  • DOI:
    10.1097/00000478-200005000-00003
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wendy A. Wells;Patricia A. Carney;Eliassen Ms;M. R. Grove;Anna N. A. Tosteson
  • 通讯作者:
    Anna N. A. Tosteson

Anna N. A. Tosteson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna N. A. Tosteson', 18)}}的其他基金

Comparative Effectiveness Core
比较有效性核心
  • 批准号:
    9982830
  • 财政年份:
    2020
  • 资助金额:
    $ 50.47万
  • 项目类别:
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
农村医疗保险患者获得癌症手术的机会和结果存在差异
  • 批准号:
    10589123
  • 财政年份:
    2020
  • 资助金额:
    $ 50.47万
  • 项目类别:
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
农村医疗保险患者获得癌症手术的机会和结果存在差异
  • 批准号:
    10112856
  • 财政年份:
    2020
  • 资助金额:
    $ 50.47万
  • 项目类别:
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
农村医疗保险患者获得癌症手术的机会和结果存在差异
  • 批准号:
    10357855
  • 财政年份:
    2020
  • 资助金额:
    $ 50.47万
  • 项目类别:
Comparative Effectiveness Core
比较有效性核心
  • 批准号:
    9279006
  • 财政年份:
    2017
  • 资助金额:
    $ 50.47万
  • 项目类别:
NIAMS Multidisciplinary Clinical Research Center
NIAMS多学科临床研究中心
  • 批准号:
    8500218
  • 财政年份:
    2012
  • 资助金额:
    $ 50.47万
  • 项目类别:
NIAMS Multidisciplinary Clinical Research Center
NIAMS多学科临床研究中心
  • 批准号:
    8917854
  • 财政年份:
    2012
  • 资助金额:
    $ 50.47万
  • 项目类别:
NIAMS Multidisciplinary Clinical Research Center
NIAMS多学科临床研究中心
  • 批准号:
    8712124
  • 财政年份:
    2012
  • 资助金额:
    $ 50.47万
  • 项目类别:
NIAMS Multidisciplinary Clinical Research Center
NIAMS多学科临床研究中心
  • 批准号:
    8289798
  • 财政年份:
    2012
  • 资助金额:
    $ 50.47万
  • 项目类别:
Comparative Effectiveness of Care Systems 8 Established 8 Emerging Modalities
护理系统的比较有效性 8 已建立 8 新兴模式
  • 批准号:
    8555542
  • 财政年份:
    2011
  • 资助金额:
    $ 50.47万
  • 项目类别:

相似海外基金

Low Dose Molecular Breast Imaging for Breast Cancer Detection
用于乳腺癌检测的低剂量分子乳腺成像
  • 批准号:
    10037007
  • 财政年份:
    2023
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Collaborative R&D
SBIR Phase I: Innovative Breast Cancer Detection Algorithm Using Infrared Images
SBIR 第一阶段:使用红外图像的创新乳腺癌检测算法
  • 批准号:
    2136325
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Standard Grant
I-Corps: Customer discovery for breast cancer detection technology
I-Corps:乳腺癌检测技术的客户发现
  • 批准号:
    2225649
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Standard Grant
Design and development of portable, high-resolution and cost-effective micromachined transducers for lung and breast cancer detection at early stages
设计和开发便携式、高分辨率且经济高效的微机械传感器,用于早期肺癌和乳腺癌检测
  • 批准号:
    569413-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Development of a Liquid Biopsy for Early Breast Cancer Detection
开发用于早期乳腺癌检测的液体活检
  • 批准号:
    468110
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Operating Grants
DEVELOPMENT OF AN AUTOMATED CARTRIDGE-BASED BREAST CANCER DETECTION ASSAY- AN ACADEMIC-INDUSTRIAL PARTNERSHIP
开发基于试剂盒的自动化乳腺癌检测方法——学术与工业合作
  • 批准号:
    10417432
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
Smaller, Smarter, and Safer Early Breast Cancer Detection in Remote Locations: The Design and Evaluation of an AI-enabled Microwave-based Portable Breast Cancer Screening Device.
更小、更智能、更安全的偏远地区早期乳腺癌检测:基于人工智能的微波便携式乳腺癌筛查设备的设计和评估。
  • 批准号:
    576197-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
DEVELOPMENT OF AN AUTOMATED CARTRIDGE-BASED BREAST CANCER DETECTION ASSAY- AN ACADEMIC-INDUSTRIAL PARTNERSHIP
开发基于试剂盒的自动化乳腺癌检测方法——学术与工业合作
  • 批准号:
    10663200
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
  • 批准号:
    576550-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 50.47万
  • 项目类别:
    Idea to Innovation
Identifying a proteomic signature for breast cancer detection in breast milk and serum
鉴定母乳和血清中乳腺癌检测的蛋白质组学特征
  • 批准号:
    10356253
  • 财政年份:
    2021
  • 资助金额:
    $ 50.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了